Global Trade in Counterfeit Goods Surges to $467 Billion, OECD Warns of Deepening Supply Chain Risks
PARIS — The global trade in counterfeit goods has soared to a staggering USD 467 billion, according to a joint […]
Thousands of Counterfeit M30 Pills Seized in Washington Containing Carfentanil, DEA Warns
WASHINGTON — The U.S. Drug Enforcement Administration (DEA) has issued a stark warning following the seizure of thousands of counterfeit
U.S. Targets Global Counterfeit Medicine Networks with New Sanctions
WASHINGTON — The U.S. Department of the Treasury has imposed sweeping sanctions on an international network accused of producing and
U.S. Targets Global Counterfeit Medicine Networks with New Sanctions Read More »
Pakistan’s Drug Regulator Cracks Down on Counterfeit Medicines Amid Supply Chain Risks
Counterfeit Medicines Seized in Nationwide Operation ISLAMABAD — The Drug Regulatory Authority of Pakistan (DRAP) has seized large consignments of
Pakistan’s Drug Regulator Cracks Down on Counterfeit Medicines Amid Supply Chain Risks Read More »
FDA Strengthens Controls on Obesity Drug Ingredient Imports to Protect Patients
WASHINGTON — The U.S. Food and Drug Administration has issued a new import alert that strengthens enforcement over obesity drug
FDA Strengthens Controls on Obesity Drug Ingredient Imports to Protect Patients Read More »
A Special Committee in Delhi Battles Fake Medicines in the Pharmaceutical Supply Chain
Delhi, India — In an urgent maneuver to protect public health, the Delhi government has announced the formation of a
A Special Committee in Delhi Battles Fake Medicines in the Pharmaceutical Supply Chain Read More »
In Pakistan, Cancer Patients Face Rising Drug Prices and Counterfeit Medicines
ISLAMABAD — Pakistan’s growing cancer crisis has exposed the fragile state of its pharmaceutical supply chain, where shortages, rising prices,
In Pakistan, Cancer Patients Face Rising Drug Prices and Counterfeit Medicines Read More »
FDA’s New Import Alert on GLP-1 Ingredients: What It Means for Drug Safety and Counterfeit Risks
Blog Post On September 5, 2025, Reuters reported that the U.S. FDA issued an import alert on GLP-1 ingredients—a move
Drug Shortages, Counterfeit Medicines, and the Urgent Need for Stronger Supply Chain Security
A Wake-Up Call from Recent U.S. Policy Moves On September 3, 2025, Global Biodefense reported on a new executive order
The Hidden Danger of Counterfeit Fentanyl: Why Stronger Verification Is Urgent
A Global Health Warning from WHO On August 29, 2025, the World Health Organization (WHO) issued a medical product alert
The Hidden Danger of Counterfeit Fentanyl: Why Stronger Verification Is Urgent Read More »